Cancer patients with which blood type are more susceptible to dangerous blood clots?

VTE is a venous blockage caused by a blood clot, the 3rd most common cardiovascular disease, and the leading cause of death in the hospital – but it is preventable.

A new study has found that cancer patients with blood types A, B and AB have a higher risk of developing venous thrombosis. Shutterstock

VTE includes deep vein thrombosis – a blood clot that often forms in the deep veins of the legs and pulmonary embolism – which is a blood clot that breaks off and causes a life-threatening blockage in a pulmonary artery.

Scientists have long tried to understand the risk factors for VTE. Doctors currently rely on tumor type or type cancer to detect people at high risk of VTE.

However, many patients without these cancers still develop life-threatening blood clots of unknown cause.

To investigate this issue, in the study, published in the medical journal Blood Advancesresearchers collected data from 1,708 patients with new or recurrent cancer from the Vienna Cancer and Thrombosis Study (CATS) data.

The researchers first divided the patients by blood type, and then classified them based on their tumor type. Patients with tumors Pancreatic Cancerstomach and brain cancers are classified as high risk for VTE.

Venous thromboembolism, which is the blockage of a vein by a blood clot, is the 3rd most common cardiovascular disease, the leading cause of death in the hospital – but is preventable. Shutterstock

Besides the types of tumors that are more likely to cause VTE, many people with milder tumors still experience dangerous blood clots.

Study author Cornelia Englisch, a doctoral student at the Medical University of Vienna (Austria), said: “Based on tumor type, we only identified 50% of people who develop VTE, leaving out up to 50% of people who develop VTE. 50% of cases,” she added.

The results show that blood type can help predict cancer patient Who is susceptible to CVD, according to Hindustan Times.

Finally, the results showed that cancer patients – blood types A, B, AB – were more likely to develop VTE 3 months after disease onset or relapse. cancer.

Dr. Englisch notes that more research is needed on this issue. Scientists hope that blood type can be a useful tool to assess the risk of VTE in cancer patients in the future, according to scientists. Hindustan Times.